Search results
PROMOTED
Start date:
Jun 10, 2026
Transcatheter edge-to-edge repair (TEER) is rapidly emerging as an important treatment option for patients with tricuspid regurgitation. Successful procedures require a detailed understanding of tricuspid valve anatomy, precise imaging guidance, and thoughtful procedural planning—especially in complex anatomies.This webinar brings together leading experts Prof Andrew Cook (UCL Institute…
View more
PROMOTED
Start date:
Jan 21, 2026
Pacemaker implantation remains one of the most common complications after TAVI. In this webinar, chaired by Prof Rafal Dworakowski (Abbott APAC Medical Affairs Director, Singapore, SG) and Dr Simon Lam (Queen Mary Hospital, Hong Kong, HK), leading specialists will focus on the anatomy of the conduction system anatomy, highlight key pre-procedural planning considerations, and share proven…
View more
Added:
6 days ago
Added:
3 weeks ago
EuroPCR 2026 – Dr Brian Bergmark (Brigham and Women's Hospital, Boston, MA, US) joins us to discuss findings from the VESALIUS-CV trial, examining the effect of evolocumab in patients who have undergone coronary stenting but have no prior myocardial infarction or stroke.VESALIUS-CV is a double-blind, randomised, placebo-controlled, multicentre phase 3 trial enrolling 12,301 high-cardiovascular…
View more
ILUMIEN-V-AERO: Study Design
Added:
5 months ago
Original Research
IVUS123 workflow for PCI
Added:
4 months ago
Review Article
Stenting Strategies in Left Main Bifurcation
Added:
4 months ago
Systematic Review
Stent Underexpansion and Aorto-ostial Lesions Management
Added:
1 year ago
Review Article
Ultimaster TANSEI in Complex Coronary Lesions
Added:
2 months ago
Original Research
Added:
11 months ago
Source:
Radcliffe Cardiology
AUTHOR: Greg GuilloryThe selection of drug-eluting stents (DES) for percutaneous coronary intervention (PCI) involves balancing efficacy against safety. The SORT OUT XI randomised trial aimed to compare a newer-generation biolimus-eluting stent with a contemporary dual-therapy sirolimus-eluting stent in a real-world patient population, providing crucial head-to-head evidence.¹SORT OUT XI was a…
View more